
Keywords: CCID50; 50% cell culture infective dose; cIPV; conventional inactivated polio vaccine; DTaP; diphtheria-tetanus-acellular pertussis combination vaccine; DU; D-antigen unit; IPV; inactivated polio vaccine; JPRI; Japan Poliomyelitis Research Institute;